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Abstract
2q Thapsigargin, an endoplasmic reticular Ca -ATPase inhibitor, induced apoptotic cell death chromatin condensation and
.DNA fragmentation accompanied by the activation of CPP32-like protease, a member of the interleukin-1b converting
 .  .enzyme protease ICE family, but not the activation of ICE-like protease. Nerve growth factor NGF completely inhibited
the cell death and CPP32-like activation induced by thapsigargin while Ac-Asp–Glu–Val–Asp-CHO, an inhibitor of
CPP32-like protease, reduced the cell death. PD98059, a specific inhibitor of Map kinase kinase, did not reduce the
protective effect of NGF on thapsigargin-induced cell death. These results suggest that calcium ion-induced apoptotic cell
death was mediated by CPP32-like, but not ICE-like, protease and was regulated by a neurotrophic factor possibly, through
the Map kinase cascade independent pathway. q 1998 Elsevier Science B.V.
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1. Introduction
Calcium ion is essential for cellular functions in-
w xcluding signal transduction 1 . However, uncon-
trolled-calcium stress has been linked causally to a
variety of neurodegenerative diseases, including is-
w xchemia, excitotoxicity and Alzheimer’s disease 2–5 .
 .N-Methyl-D-aspartate NMDA , an agonist of an
NMDA subtype of glutamate receptor, induced a
marked calcium influx immediately after treatment of
Abbreviations: NGF, nerve growth factor; ICE, interleukin-1b
 X X .converting enzyme; PD98059, 2- 2 -amino-3 -methoxyphenyl -
oxanaphthalen-4-one; LDH, lactate dehydrogenase; TG, thapsi-
gargin; CHX, cycloheximide; DMEM, Dulbecco’s modified Ea-
gle’s medium
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w xneurons such as of the spinal cord or cortex 3,6 .
b-Amyloid protein was reported to increase calcium
w xaccumulation 7 . To know the mechanisms of cal-
cium stress-induced cell death, we examined the ef-
fect of thapsigargin, a specific inhibitor of endoplas-
2q w xmic reticular Ca -ATPase 8,9 , on the rat pheochro-
mocytoma PC12 cell line which shows a sympathetic
neuron-like phenotype in response to nerve growth
 . w xfactor NGF 10 . Thapsigargin, which increases
w 2qxCa , has been used as an important experimentali
tool in a large number of Ca2q-dependent intra-
cellular functions, including control of cellular growth
w x11,12 .
The best characterized neurotrophic molecule is
the NGF, which supports the development and sur-
vival of peripheral sympathetic and sensory neurons
w x13 . It also has been shown in in vitro experiments
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that NGF is essential for the development and main-
w xtenance of septal cholinergic neurons 14,15 . The
differentiation of neurons by neurotrophins such as
NGF is mediated by the activation of the Map kinase
cascade through several steps including Ras and Raf-1
w xkinase 16–18 .
Genetic studies in the roundworm Caenorhabditis
elegans identified the ced3 gene, whose functioning
is required for all of the developmentally pro-
w xgrammed death in the hermaphrodite 19 . CED3 is a
cysteine protease that cleaves protein at Asp–X pep-
tide bonds. Recent evidence has implicated the
CEDrICE-related protease CPP32 in the effector
w xpathway in non-neuronal cells 20,21 . In the present
study, we reported that thapsigargin induced apop-
totic cell death and CPP32-like activation in PC12
cells and that NGF or a peptide inhibitor of CPP32-
like protease inhibited it.
2. Materials and methods
2.1. Materials
7S NGF from mouse submaxillary glands was
 .purchased from Sigma St. Louis, USA , Hoechst
 .33258 bis-benzimide from Molecular Probes
 .Oregon, USA , Ac-Asp–Glu–Val–Asp-4-methyl-
 .coumaryl-7-amide Ac-DEVD-MCA , Ac-Tyr–Val–
 .Ala–Asp-coumaryl-7-amide Ac-YVAD-MCA , Ac-
DEVD-CHO tetrapeptide aldehyde and 7-amino-4-
 .methyl-coumarin AMC from Peptide Institute
 .Osaka, Japan , and PD98059 from BIOMOL Re-
 .search Laboratories PA, USA . Indo-1 and its ace-
toxymethyl ester and other chemicals were purchased
 .from Wako Pure Chemical Osaka, Japan .
2.2. Assessment of cellular injury
PC12 cells were obtained from a RIKEN cell bank
 .Ibaragi, Japan and subcultured in 48-well plates or
35 mm dishes coated with poly-D-lysine at a density
of about 2.5=105 cells per well or 1=106 cells per
dish in a DMEM medium supplemented with 5%
precolostrum newborn calf serum and 5% horse serum
for 1–2 days before the experiment. Cells were
washed twice with DMEM and then 0.5 ml of DMEM
was added. Unless specified in Section 3, no serum
was added to DMEM because the serum itself has a
 .relatively high lactate dehydrogenase LDH activity
 .about 30% of the value of ‘‘No addition’’ . LDH
activity of the serum itself was subtracted from each
value. Thapsigargin was added to cells with or with-
out 7S NGF and other reagents. Cells were then
maintained under 95% airr5% CO for 18 h at 378C.2
Morphological changes of cells were checked
throughout the course of the experiment by a phase-
contrast microscopy; cell viability was checked by
trypan blue staining. Cell injury was assessed by
measurement of the activity of LDH released into the
medium for 18 h after the treatment.
2.3. Analysis of DNA fragmentation
Low molecular weight DNA was isolated from
6 w x3=10 cells as described by Hockenbery et al. 22 .
 .Agarose 1.2% gel electrophoresis of DNA was
 .performed in a 40 mM Tris–HCl buffer pH 8.1
containing 2 mM EDTA. After electrophoresis for
 .60 min, gels were treated with RNase 10 mgrml for
3 h at 378C and then stained with ethidium bromide
 .0.5 mgrml for 15 min at room temperature.
2.4. Nuclear staining and morphology
Cells were fixed with a 10% formalin neutral
 .buffer solution pH 7.4 for 5 min at room tempera-
ture. Cells were washed with distilled water and then
stained with 8 mgrml H33258 for 5 min. After a
5 min washing with distilled water, nuclear morphol-
ogy was observed under a fluorescence microscope
 .Olympus, IX70 model .
2.5. Measurement of thapsigargin-induced calcium
accumulation in cells
Calcium accumulation in PC12 cells was moni-
tored by Ca2q-sensitive fluorescent dye, Indo-1, using
 . w xACAS 570 Meridian as described previously 3 .
2.6. Acti˝ity of CPP32 and ICE protease
Cells were treated with 2 or 10 nM thapsigargin in
the presence or absence of NGF for 18 h. Cells were
 .washed with phosphate buffered-saline PBS and
 .suspended in 50 mM Tris–HCl pH 7.4 , 1 mM EDTA
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and 10 mM EGTA. Cells were treated with 10 mM
digitonin for 10 min. Lysates were then obtained by
centrifugation at 20 000=g for 5 min, and cleared
lysates containing 50–100 mg protein were incubated
with 50 mM of enzyme substrate Ac-DEVD-MCA
and Ac-YVAD-MCA for CPP32 and ICE, respec-
tively, at 378C for 5–10 min. Levels of AMC were
measured using a spectrofluorometer Hitachi 850,
.Japan with excitation at 380 nm and emission at
460 nm, and the activity was expressed as pmol AMC
releaserminrmg protein.
3. Results and discussion
 .Thapsigargin 20 nM increased LDH release from
PC12 cells regardless of the presence of calf serum
  ..Fig. 1 A . Treatment of PC12 cells with thapsigar-
 .gin 10–20 nM increased LDH release from the cells
depending on the concentration of thapsigargin Fig.
 ..1 B . The loss of cell viability was also confirmed
 .by phase-contrast microscopy Fig. 2 and trypan
 .blue exclusion data not shown . Cells treated with
10 nM thapsigargin shrank by phase-contrast observa-
tion and showed chromatin condensation and nuclear
fragmentation detected by staining with H33258 Fig.
.  .2 and DNA fragmentation data not shown . Thapsi-
gargin increased the number of apoptotic cells Table
.1 . A small number of cells were damaged by serum
deprivation through apoptosis depending on experi-
 .mental conditions Fig. 1 and Table 1 . As reported
w xpreviously 23 , serum withdrawal induced apoptotic
cell death in PC12 cells. Thapsigargin probably in-
duces apoptosis of PC12 cells by a different mecha-
nism from that of serum deprivation because thapsi-
gargin induced apoptotic cell death in the presence of
  . .serum Fig. 1 A and Table 1 .
The neuron-like processes increased in length on
culturing the cells with 100 ngrml NGF for 18 h
 .Fig. 2 . NGF completely inhibited LDH release from
the cells, chromatin condensation and nuclear frag-
mentation, as induced by treatment of the cells with
 .thapsigargin for 18 h Figs. 1 and 2 and Table 1 .
w 2qxThapsigargin produced a sustained increase in Ca i
2q  .in the presence of extracellular Ca Fig. 3 , while
w 2qxthapsigargin produced a transient increase in Ca i
2q  .in the absence of extracellular Ca data not shown .
The calcium accumulation by 10 nM thapsigargin
Fig. 1. Thapsigargin-induced LDH release from PC12 cells and
 .protection by NGF in the presence or absence of serum. A Cells
were treated with 20 nM thapsigargin in the presence or absence
of 100ngrml NGF in a DMEM containing calf serum as de-
scribed in Section 2. Each value represents the mean"S.E.M of
)  .  .three sister cultures. P -0.01 vs. no addition . B Cells were
treated with various concentrations of thapsigargin in the pres-
 .  .ence dotted bars or absence open bars of 100ngrml NGF in a
serum-free DMEM. Each value represents the mean"S.E.M. of
) three sister cultures. P -0.01 vs. each control cultures without
.NGF .
was not significantly inhibited by treatment of the
cells with NGF, indicating that NGF did not modify
2q  .the Ca concentration in the cells Fig. 3 . PC12
cells treated with NGF exhibit characteristics of sym-
pathetic neurons including the extension of neurites
w xin need of the new protein synthesis 10 . We then
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Fig. 2. Effect of NGF on morphology of the cytotoxicity produced by thapsigargin. Cells were treated with thapsigargin in the presence or
 .  .  .  .  .absence of NGF. A Phase-contrast photomicrographs, a Control, b 10 nM thapsigargin, c 100 ngrml NGF, d 10 nM thapsigargin
 .  .  .  .  .q100 ngrml NGF. B Nuclear morphology of cells stained with H33258, a Control, b 10 nM thapsigargin, c 100 ngrml NGF, d
10 nM thapsigarginq100 ngrml NGF. See Section 2 for further details of the method.
Table 1
Thapsigargin-induced apoptotic cell death
 .Apoptotic cells %
)ySerum No addition 9.4"1.1
Thapsigargin 72"1.9
)NGFqThapsigargin 5.1"0.3
)NGF 4.0"1.5
)qSerum No addition 2.6"0.9
Thapsigargin 67"1.8
)NGFqThapsigargin 2.7"0.7
)NGF 3.0"0.2
Cells were treated with 20 nM thapsigargin in the presence or
absence of NGF. Nuclear staining with H33258 was done as
described in Section 2. The number of apoptotic cells was
counted by the observation of condensed or fragmented nuclear.
Each value represents the ratio of apoptotic cells"S.E.M of three
 .sister cultures 50–100cells .
)  .P -0.01 vs. thapsigargin only .
Fig. 3. Effect of NGF on thapsigargin-induced calcium ion
 .accumulation. Cells were cultured for 1 day in the presence v
 .  .or absence ‘ of 100ngrml NGF. Thapsigargin 10 nM was
added at arrow. Each value represents the mean"S.E.M. for
20 cells. See Section 2 for further details of the methods.
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 .Fig. 4. Protective effect of NGF on thapsigargin-induced cell injury in the presence of cycloheximide. A Phase-contrast photomicro-
 .  .  .  .  .  .graphs of cells treated with thapsigargin for 18 h. a no addition, b thapsigargin only 10 nM , c NGF 100 ngrml q thapsigargin, d
 .  .  .  .NGF only, e NGFqcycloheximide 1 mgrml , f cycloheximideqNGFq thapsigargin. B LDH release from cells treated with
))  .thapsigargin. Each value represents the mean"S.E.M. of three sister cultures, P-0.01 vs. thapsigargin only .
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examined whether the new protein synthesis is neces-
sary for the NGF-dependent survival. Cycloheximide,
an inhibitor of protein synthesis, did not reduce the
protective effect of NGF on thapsigargin-induced cell
death; cycloheximide did inhibit NGF-induced neu-
 .rite outgrowth Fig. 4 . Using neurite outgrowth in
PC12 cells as a measure of differentiation, studies
have implicated the MAP kinase pathway in NGF
 .signaling. We used the specific inhibitor PD98059
w xof Map kinase kinase 24 , which blocks the differen-
tiation of PC12 cells induced by NGF, to examine if
the protective effect of NGF on thapsigargin-induced
apoptosis is dependent on the Map kinase pathway.
As shown in Fig. 5, PD98059 did not reduce the
protective effect of NGF on thapsigargin-induced
LDH release, while NGF-dependent neurite out-
 .growth was reduced data not shown .
Recently, it is reported that interleukin-1b convert-
 .ing enzyme ICE -like cysteine protease family is
essential for apoptotic cell death induced by several
w xstimuli including Fas ligand and TNF 20,21 . There-
fore, we measured the activities of CPP32-like and
ICE-like protease using Ac-DEVD-MCA and Ac-
YVAD-MCA as the enzyme substrates, respectively,
Fig. 5. Protective effect of NGF on thapsigargin-induced LDH
release from cells in the presence of PD98059. Cells were
pretreated with or without 100 mM PD98059 for 30 min and were
incubated with 10 nM thapsigargin in the presence or absence of
NGF for 18h. Each value represents the mean"S.E.M. of three
))  .sister culture, P -0.01 vs. thapsigargin only .
after treatment of the cells with thapsigargin for 18 h.
Thapsigargin increased the CPP32-like activity, but
  .  ..not the ICE-like activity Fig. 6 A and B . NGF
inhibited the thapsigargin-induced activation of
CPP32 depending on the concentration of NGF Fig.
.7 . Ac-DEVD-CHO tetrapeptide aldehyde inhibitor
 .100–200 mM of CPP32 attenuated apoptotic cell
death and CPP32 activation induced by 10 nM thapsi-
  .gargin LDH release Mean"S.E.M., ns3 ; No
addition 27.7"1.9), thapsigagin 53.3"2.1, 50 mM
Ac-DEVD-CHOq thapsigargin 45.2"2.2 ), 100 mM
Ac-DEVD-CHO q thapsigargin 39.5 " 0.84 ) ,
200 mM AC-DEVD-CHO q thapsigargin 34.3 "
) ) ..1.9 , P-0.05 vs. thapsigargin only .
Ca2q ionophores were used to induce apoptosis in
w x w xseveral cells such as thymocyte 25 , PC12 cells 26
w xand cortical cells 27 . However, the existence of
various non-specific effects of Ca2q ionophores has
raised the question whether effects other than the
w 2qxincrease in Ca could be involved in the initiationi
w xof apoptosis 28–30 . Therefore, we used the selec-
tive endoplasmic reticular Ca2q-ATPase inhibitor
w xthapsigargin 8,9 in the present study to increase the
w 2qxCa . The mechanism of thapsigargin-mediated in-i
w 2qx 2qcrease in Ca involves the initial release of Cai
from intracellular, non-mitochondrial Ca2q pools,
which in turn promote an influx of extracellular Ca2q
w x9 . Thapsigargin induced cell death accompanied by
chromatin condensation and nuclear fragmentation
 .Fig. 2 , suggesting the apoptotic cell death. Re-
cently, several reports showed that thapsigargin could
induce apoptotic cell death in other cell types such as
thymocytes, lymphoma cells or hematopoietic cells
w x31–34 .
Apoptotic cell death and CPP32-like activation
induced by thapsigargin were attenuated by the pres-
 .ence of NGF Figs. 1, 6 and 7 and Table 1 . The
mechanism whereby NGF protects thapsigargin-in-
duced apoptosis is unknown at present. The protec-
tive effect of NGF is not dependent on the new
protein synthesis because cycloheximide did not re-
duce the protective effect of NGF on thapsigargin-in-
 .duced cell death Fig. 4 . Cycloheximide, however,
  ..did inhibit neurite outgrowth Fig. 4 A . Moreover,
cycloheximide itself did not inhibit the thapsigargin-
 .induced apoptosis data not shown , suggesting that
the machinery for apoptosis already existed in the
cells. NGF binds to and activates the tyrosine kinase
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Fig. 6. Effect of NGF on thapsigargin-induced CPP32-like and ICE-like protease activities. Cells were incubated with 2 or 10 nM
 .  .  .  .thapsigargin in the presence dotted bar or absence open bar of 100 ngrml NGF for 18 h. Activities of CPP32-like A and ICE-like B
protease were measured as described in Section 2. Each value represents the mean"S.E.M. of three sister cultures. ) P-0.05,
))  .P-0.01 vs. no addition .
of TrkA, the high affinity NGF receptor. Phosphoty-
rosyl motifs on TrkA bind Shc proteins, which bind
and activate GrbrmSOS, thereby activating Ras. Ras
activation results in activation of the protein kinases
such as raf-1 followed by activation of Map kinase
Fig. 7. Effect of NGF on thapsigargin-induced LDH release and
CPP32-like protease activity. Cells were incubated with 10 nM
thapsigargin in the presence or absence of 10–100ngrml NGF or
 .Ac-DEVD-CHO tetrapeptide aldehyde inhibitor 200 mM for
 .18 h. LDH release open bars and CPP32-like protease activity
 .dotted bars were measured as described in Section 2. Each
value represents the mean"S.E.M. of three sister culture. )P -
 .0.01 vs. thapsigargin only .
w xkinase and Map kinase 16–18 . As shown in Fig. 5,
PD98059, a specific inhibitor of MAP kinase kinase
did not inhibit the protective effect of NGF, suggest-
ing that the Map kinase cascade is not necessary for
survival. This agrees with results of recent reports
w x35,36 . An alternative signal transduction pathway
different from Map kinase cascade after ras andror
raf activation by NGF maybe involved in the mainte-
nance of cells. NGF may regulate the BCL-2 family
such as BAD, which is phosphorylated by raf-1
kinase and then regulate the release of factors such as
cytochrome c from mitochondria, necessary for apop-
w xtosis of some kinds of cells 37–39 .
The apoptotic cell death was accompanied by the
activation of CPP32-like protease, but not ICE-like,
 .and the inhibitory peptide Ac-DEVD-CHO of
CPP32-like protease reduced the thapsigargin-in-
 .duced cell death Fig. 7 . The possibility that other
ICE family proteases are involved in thapsigargin-in-
duced apoptosis cannot be ruled out, because the
specificity of the peptide substrate may not be so
w x w xstrict 40 . Recently, it has been reported 20,21,41
that CPP32 is a key enzyme relating to the down-
stream of events on apoptosis induced by several
w xstimuli including FAS antigen. Also, Enari et al. 20
reported that sequential activation of ICE-like and
CPP32-like proteases occurred during Fas-mediated
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apoptosis. On the other hand, Kuida et al. reported
w x42 that apoptosis was decreased in the brain in
CPP32-deficient mice. Interestingly, Fas-mediated
apoptosis was normal in thymocyte and hepatocyte of
the CPP32-deficient mice. The mechanism whereby
calcium activates CPP32-like protease is unknown at
present. Reactive oxygen species may mediate the
activation of CPP32-like protease because an antioxi-
dant such as TMPO, a spin trapper, has attenuated
thapsigargin-induced cell death our unpublished
.data .
In conclusion, thapsigargin activates CPP32-like
protease followed by apoptotic cell death, while NGF
inhibits the activation of CPP32-like protease and cell
death.
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